Zobrazeno 1 - 10
of 726
pro vyhledávání: '"Valerie W, Rusch"'
Autor:
Zerihun Abebe, Abebe Bekele, Augustin Sendegeya, David J Bradley, Yayehyirad M Ejigu, Kara L Neil, Emmanuel Rusingiza, Gaston Nyirigira, Valerie W Rusch, Bertrand Byishimo, Roda Uwayesu, Menelas Nkeshimana, Yvan Butera
Publikováno v:
BMJ Global Health, Vol 9, Iss 10 (2024)
Paediatric cardiovascular diseases have been referred to as diseases of injustice as access to care is inequitable globally. For example, Africa only has 78 cardiac centres, with 22 located in Sub-Saharan Africa. Most of these centres rely on visitin
Externí odkaz:
https://doaj.org/article/58d6d51096cc407390e7c4f7608d0722
Autor:
Michael Offin, Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta Chavan, Nisargbhai S. Shah, Parvathy Manoj, Katia Ventura, Viola Allaj, Elisa de Stanchina, William Travis, Marc Ladanyi, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, John T. Poirier, Marjorie G. Zauderer, Charles M. Rudin, Triparna Sen
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-19 (2022)
Abstract Background Diffuse pleural mesothelioma (DPM) is an aggressive malignancy that, despite recent treatment advances, has unacceptably poor outcomes. Therapeutic research in DPM is inhibited by a paucity of preclinical models that faithfully re
Externí odkaz:
https://doaj.org/article/7bae9e3ad4f54b39847547d219cf9c55
Autor:
Navin K. Chintala, Jennie K. Choe, Erin McGee, Rebecca Bellis, Jasmeen K. Saini, Srijita Banerjee, Andre L. Moreira, Marjorie G. Zauderer, Prasad S. Adusumilli, Valerie W. Rusch
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe attenuated, genetically engineered vaccinia virus has been shown to be a promising oncolytic virus for the treatment of patients with solid tumors, through both direct cytotoxic and immune-activating effects. Whereas systemically admini
Externí odkaz:
https://doaj.org/article/3273ec9012d64f429fc5aadf18ca215f
Autor:
Andreas Rimner, MD, Prasad S. Adusumilli, MD, Michael D. Offin, MD, Stephen B. Solomon, MD, Etay Ziv, MD, Sara A. Hayes, MD, Michelle S. Ginsberg, MD, Jennifer L. Sauter, MD, Daphna Y. Gelblum, MD, Annemarie F. Shepherd, MD, David M. Guttmann, MD, Jordan E. Eichholz, MS, Zhigang Zhang, PhD, Erika Ritter, BS, Phillip Wong, PhD, Afsheen N. Iqbal, MD, Robert M. Daly, MD, Azadeh Namakydoust, MD, Henry Li, BS, Megan McCune, BS, Emily H. Gelb, BS, Neil K. Taunk, MD, Donata von Reibnitz, MD, Neelam Tyagi, PhD, Ellen D. Yorke, PhD, Valerie W. Rusch, MD, Marjorie G. Zauderer, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100440- (2023)
Introduction: Single-agent monoclonal antibody therapy against programmed death-ligand 1 (PD-L1) has modest effects in malignant pleural mesothelioma. Radiation therapy can enhance the antitumor effects of immunotherapy. Nevertheless, the safety of c
Externí odkaz:
https://doaj.org/article/8350f1d8ba0d4d41ad97457d20805a67
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
Autor:
Jennie K. Choe, MD, Amy Zhu, BS, Alexander J. Byun, MD, Junting Zheng, MS, Kay See Tan, PhD, Joe Dycoco, BS, Manjit S. Bains, MD, Matthew J. Bott, MD, Robert J. Downey, MD, James Huang, MD, James M. Isbell, MD, Daniela Molena, MD, Valerie W. Rusch, MD, Bernard J. Park, MD, Gaetano Rocco, MD, Smita Sihag, MD, David R. Jones, MD, Prasad S. Adusumilli, MD, FACS
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100362- (2022)
Introduction: Anatomical resection—often by lobectomy—is the standard of care for patients with early stage NSCLC. With increased diagnosis, survival, and prevalence of persons with early stage NSCLC, the incidence of second primary NSCLC, and co
Externí odkaz:
https://doaj.org/article/53fca54eaa1942dcadf612d7f6b69aae
Autor:
Thomas Boerner, Caitlin Harrington, Kay See Tan, Prasad S. Adusumilli, Manjit S. Bains, Matthew J. Bott, Robert J. Downey, James Huang, David H. Ilson, James M. Isbell, Yelena Y. Janjigian, Bernard J. Park, Gaetano Rocco, Valerie W. Rusch, Smita Sihag, Abraham J. Wu, David R. Jones, Daniela Molena
Publikováno v:
Annals of Surgery. 277:781-788
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e251053c3ddd07edf71c93c409cfc0
https://doi.org/10.1097/sla.0000000000005798
https://doi.org/10.1097/sla.0000000000005798
Autor:
Michael Offin, Dilanka L. De Silva, Jennifer L. Sauter, Jacklynn V. Egger, Ellen Yorke, Prasad S. Adusumilli, Andreas Rimner, Valerie W. Rusch, Marjorie G. Zauderer
Publikováno v:
Journal of Thoracic Oncology. 17:1428-1432
Primary pericardial mesothelioma (PPM) has no accepted standard-of-care treatment options with management and outcomes often extrapolated from diffuse pleural mesothelioma. Disease-specific research is needed to better define PPM. We report our insti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e396e9746017a27da5c50595d697b44c
https://doi.org/10.1016/j.jtho.2022.08.017
https://doi.org/10.1016/j.jtho.2022.08.017
Autor:
Valerie W, Rusch
Publikováno v:
Journal of Surgical Oncology. 126:921-925
During the past 50 years, there has been a remarkable transformation in the management of lung and esophageal cancers. Improved methods of diagnosis, better staging and patient selection for surgery, the advent of minimally invasive approaches to res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f635bd3b4d93d811eae2526d7a82c0
https://doi.org/10.1002/jso.27033
https://doi.org/10.1002/jso.27033
Autor:
Caitlin A, Harrington, Rebecca A, Carr, Meier, Hsu, Kay See, Tan, Smita, Sihag, Prasad S, Adusumilli, Manjit S, Bains, Matthew J, Bott, James M, Isbell, Bernard J, Park, Gaetano, Rocco, Valerie W, Rusch, David R, Jones, Daniela, Molena
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 164:411-419
Little is known about the pattern of nodal metastases in patients with esophageal adenocarcinoma who have received neoadjuvant chemoradiation and undergone surgery. We sought to assess this pattern and evaluate its association with prognosis.All pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bec76b619a2a2d4136fcb770ec1014a9
https://doi.org/10.1016/j.jtcvs.2021.11.094
https://doi.org/10.1016/j.jtcvs.2021.11.094
Autor:
Adam J. Schoenfeld, Hira A. Rizvi, Danish Memon, Narek Shaverdian, Matthew J. Bott, Jennifer L. Sauter, C. Jillian Tsai, Jayon Lihm, David Hoyos, Andrew J. Plodkowski, Rocio Perez-Johnston, Peter Sawan, Jacklynn V. Egger, Benjamin D. Greenbaum, Andreas Rimner, Gregory J. Riely, Charles M. Rudin, Valerie W. Rusch, Daniel R. Gomez, Matthew D. Hellmann
Publikováno v:
Clinical Cancer Research. 28:3797-3803
Purpose: Clinical patterns and the associated optimal management of acquired resistance to PD-(L)1 blockade are poorly understood. Experimental Design: All cases of metastatic lung cancer treated with PD-(L)1 blockade at Memorial Sloan Kettering were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0028fe3841fff93e2b97cef720ffcb40
https://doi.org/10.1158/1078-0432.ccr-22-0657
https://doi.org/10.1158/1078-0432.ccr-22-0657